Related references
Note: Only part of the references are listed.CYP4F2 genetic variant alters required warfarin dose
Michael D. Caldwell et al.
BLOOD (2008)
Genetic determinants of response to warfarin during initial anticoagulation
Ute I. Schwarz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues
Brian F. Gage et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2008)
γ-Glutamyl carboxylase (GGCX) tagSNPs have limited utility for predicting warfarin maintenance dose
M. J. Rieder et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Imputation-based analysis of association studies: Candidate regions and quantitative traits
Bertrand Servin et al.
PLOS GENETICS (2007)
Identifying the genotype phenotype:: a role model behind the found in VKORC1 and its association with warfarin dosing
Dana C. Crawford et al.
PHARMACOGENOMICS (2007)
Evaluation of Genetic Factors for Warfarin Dose Prediction
Michael D. Caldwell et al.
CLINICAL MEDICINE & RESEARCH (2007)
Association of warfarin dose with genes involved in its action and metabolism
Mia Wadelius et al.
HUMAN GENETICS (2007)
Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose:: a prospective study
John F. Carlquist et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2006)
The pharmacogenomics of Warfarin - Closing in on personalized medicine
Allan E. Rettie et al.
MOLECULAR INTERVENTIONS (2006)
VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status:: Interaction between both genotypes affects overanticoagulation
Tom Schalekamp et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P4502C9 gene polymorphisms on warfarin dose requirements
CL Aquilante et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
MJ Rieder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation
M Stephens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
The patterns of natural variation in human genes
DC Crawford et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS (2005)
A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin
G D'Andrea et al.
BLOOD (2005)
Pattern of sequence variation across 213 environmental response genes
RJ Livingston et al.
GENOME RESEARCH (2004)
Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits
S Purcell et al.
BIOINFORMATICS (2003)
Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy
MK Higashi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
CYP2C9 Ile(359) and Leu(359) variants: enzyme kinetic study with seven substrates
K Takanashi et al.
PHARMACOGENETICS (2000)